what bmi qualifies for tirzepatide weight loss eligibility and benefits 📢 Important Update: New Prescribing

These parts help control how much you want to eat and how well your body uses insulin

Taking it every other week is not supported by clinical evidence and may allow appetite to return between doses, increasing the risk of weight regain

It was with my doctors approval that I began my journey

In a post hoc analysis of the SURPASS-4 trial in people with type 2 diabetes and high CV risk, the first-in-class dual GIP/GLP-1 RA tirzepatide was found to reduce albuminuria and slow the rate of eGFR decline compared to insulin glargine (Heerspink et al, 2022)

Oral semaglutide ($289/month) eliminates needles but requires careful timing on an empty stomach and shows slower absorption, making it ideal for needle-averse patients willing to trade immediacy for convenience